Autor: "Takano, S." - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Daily irradiation versus irradiation at two- to three-day intervals in stereotactic radiotherapy for patients with 1-5 brain metastases: study protocol for a multicenter open-label randomized phase II trial.
Autorzy:: Tomita N; Department of Radiation Oncology, Nagoya City University Hospital, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi, 467-8601, Japan. .
Ishiyama H; Department of Radiation Oncology, Kitasato University School of Medicine, 1-15-1 Kitasato, Sagamihara, Kanagawa, 252-0329, Japan.
Makita C; Department of Radiation Oncology, Gifu University Hospital, 1-1 Yanagido, Gifu, 501-1194, Japan.
Ohshima Y; Department of Radiology, Aichi Medical University, 1-1 Yazako-Karimata, Nagakute, Aichi, 480-1195, Japan.
Nagai A; Department of Radiation Oncology, Nagoya City University East Medical Center, 1-2-23 Wakamizu, Chikusa-ku, Nagoya, Aichi, 464-8547, Japan.
Baba F; Department of Radiation Oncology, Nagoya City University West Medical Center, 1-1-1 Hirate-cho, Kita-ku, Nagoya, Aichi, 462-8508, Japan.
Kuno M; Department of Radiation Oncology, Ichinomiya Municipal Hospital, 2-2-22 Bunkyo, Ichinomiya, Aichi, 491-8558, Japan.
Otsuka S; Department of Radiation Oncology, Okazaki City Hospital, 3-1 Goshoai, Koryuji-cho, Okazaki, Aichi, 444-8553, Japan.
Kondo T; Department of Radiation Oncology, Nagoya Ekisaikai Hospital, 4-66 Syonen-cho, Nakagawa-ku, Nagoya, Aichi, 454-8502, Japan.
Sugie C; Department of Radiation Oncology, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, 2-9 Myoken-cho, Showa-ku, Nagoya, Aichi, 466-8650, Japan.
Kawai T; Department of Radiation Oncology, Nagoya City University Hospital, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi, 467-8601, Japan.
Takaoka T; Department of Radiation Oncology, Nagoya City University Hospital, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi, 467-8601, Japan.
Okazaki D; Department of Radiation Oncology, Nagoya City University Hospital, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi, 467-8601, Japan.
Torii A; Department of Radiation Oncology, Nagoya City University Hospital, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi, 467-8601, Japan.
Niwa M; Department of Radiation Oncology, Nagoya City University Hospital, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi, 467-8601, Japan.
Kita N; Department of Radiation Oncology, Nagoya City University Hospital, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi, 467-8601, Japan.
Takano S; Department of Radiation Oncology, Nagoya City University Hospital, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi, 467-8601, Japan.
Kawakami S; Department of Radiation Oncology, Kitasato University School of Medicine, 1-15-1 Kitasato, Sagamihara, Kanagawa, 252-0329, Japan.
Matsuo M; Department of Radiation Oncology, Gifu University Hospital, 1-1 Yanagido, Gifu, 501-1194, Japan.
Kumano T; Department of Radiation Oncology, Gifu University Hospital, 1-1 Yanagido, Gifu, 501-1194, Japan.
Ito M; Department of Radiology, Aichi Medical University, 1-1 Yazako-Karimata, Nagakute, Aichi, 480-1195, Japan.
Adachi S; Department of Radiology, Aichi Medical University, 1-1 Yazako-Karimata, Nagakute, Aichi, 480-1195, Japan.
Abe S; Department of Radiology, Aichi Medical University, 1-1 Yazako-Karimata, Nagakute, Aichi, 480-1195, Japan.
Murao T; Department of Radiation Oncology, Ichinomiya Municipal Hospital, 2-2-22 Bunkyo, Ichinomiya, Aichi, 491-8558, Japan.
Hiwatashi A; Department of Radiation Oncology, Nagoya City University Hospital, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi, 467-8601, Japan.; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2022 Dec 05; Vol. 22 (1), pp. 1259. Date of Electronic Publication: 2022 Dec 05.
Typ publikacji:: Clinical Trial Protocol; Journal Article
MeSH Terms:: Radiosurgery*/adverse effects
Radiosurgery*/methods
Brain Neoplasms*/secondary
Humans ; Karnofsky Performance Status ; Randomized Controlled Trials as Topic ; Multicenter Studies as Topic ; Clinical Trials, Phase II as Topic

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Maximum resection and immunotherapy improve glioblastoma patient survival: a retrospective single-institution prognostic analysis.
Autorzy:: Ishikawa E; Department of Neurosurgery, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan. .
Sugii N; Department of Neurosurgery, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan.
Matsuda M; Department of Neurosurgery, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan.
Kohzuki H; Department of Neurosurgery, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan.
Tsurubuchi T; Department of Neurosurgery, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan.
Akutsu H; Department of Neurosurgery, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan.
Takano S; Department of Neurosurgery, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan.
Mizumoto M; Department of Radiation Oncology, Proton Medical Research Center, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Sakurai H; Department of Radiation Oncology, Proton Medical Research Center, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Matsumura A; Department of Neurosurgery, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan.; Pokaż więcej
Źródło:: BMC neurology [BMC Neurol] 2021 Jul 19; Vol. 21 (1), pp. 282. Date of Electronic Publication: 2021 Jul 19.
Typ publikacji:: Journal Article
MeSH Terms:: Brain Neoplasms/*mortality
Brain Neoplasms/*therapy
Glioblastoma/*mortality
Glioblastoma/*therapy
Aged ; Antineoplastic Agents, Immunological ; Cancer Vaccines ; Female ; Humans ; Male ; Middle Aged ; Multivariate Analysis ; Prognosis ; Proton Therapy ; Retrospective Studies